These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13309805)

  • 1. [Treatment of malignant systemic diseases].
    VIDEBAEK A
    Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical report on ACTH therapy of some malignant diseases of the hemopoietic system].
    LENTI G; MOLINATTI GM; PIZZINI A; GAMNA G
    Minerva Med; 1952 Dec; 43(97):1227-34. PubMed ID: 13036734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].
    GARCIGA CE
    Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of radioactive phosphorus in the therapy of leukemia, polycythemia vera and lymphomas: a report of 10 years' experience.
    CHODOS RB; ROSS JF
    Ann Intern Med; 1958 May; 48(5):956-77. PubMed ID: 13534214
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of chemotherapeutic compounds in the reticuloses.
    PATERSON E
    Br J Cancer; 1958 Sep; 12(3):332-41. PubMed ID: 13596485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical use of triethylene melamine.
    KRAVITZ SC; DIAMOND HD; CRAVER LF
    Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
    [No Abstract]   [Full Text] [Related]  

  • 8. METHYGLYOXAL-BIS-GUANYLHYDRAZONE--AN ACTIVE AGENT AGAINST HODGKIN'S DISEASE AND ACUTE MYELOBLASTIC LEUKEMIA.
    HOLLAND JF; REGELSON W; SELAWRY OS; COSTA G
    Acta Unio Int Contra Cancrum; 1964; 20():352-3. PubMed ID: 14151926
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tentative therapy with colchicine in some malginant blood disorders].
    CONSOLI G
    G Ital Chemioter; 1954; 1(1):161-3. PubMed ID: 13191613
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioactive phosphorus. III. In the treatment of malignant lymphomas, plasma-cell myeloma, Ewing's sarcoma, and osteogenic sarcoma.
    DIAMOND HD; CRAVER LF; WOODARD HQ
    Cancer; 1957; 10(1):143-50. PubMed ID: 13413811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial clinical and hematological findings on the use of sarcochlorine in the treatment of various malignant blood and lymph node lymphatic diseases].
    CONSOLI G; VIOLANTE A
    Tumori; 1956; 42(6):931-7. PubMed ID: 13409649
    [No Abstract]   [Full Text] [Related]  

  • 12. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. II. BLOOD COMPLEMENT VALUES IN LEUKAEMIA, MALIGNANT LYMPHOMA, AND MYELOMA.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1963; 10():605-19. PubMed ID: 14103648
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE ARTICULAR MANIFESTATIONS OF CHRONIC BLOOD DISEASES].
    GUERIN C
    Rev Rhum Mal Osteoartic; 1963 Dec; 30():841-2. PubMed ID: 14116408
    [No Abstract]   [Full Text] [Related]  

  • 14. [Status and trends in hematology].
    Stobbe H
    Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527
    [No Abstract]   [Full Text] [Related]  

  • 15. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
    Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of malignancies of the reticuloendothelial system.
    GHRIST TD
    J Iowa State Med Soc; 1963 Feb; 53():72-82. PubMed ID: 13947558
    [No Abstract]   [Full Text] [Related]  

  • 17. THE TREATMENT OF LEUKAEMIA AND ALLIED DISORDERS.
    INNES J
    Br J Clin Pract; 1964 Nov; 18():681-7. PubMed ID: 14230850
    [No Abstract]   [Full Text] [Related]  

  • 18. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
    POPA M; POPA G; VEIZA L
    Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
    [No Abstract]   [Full Text] [Related]  

  • 19. LEUKEMIC NEOPLASIA IN THE DOG.
    SMITH HA
    Ann N Y Acad Sci; 1963 Nov; 108():633-41. PubMed ID: 14081509
    [No Abstract]   [Full Text] [Related]  

  • 20. [GRANULOCYTE ZINC CONTENT IN NORMAL SUBJECTS AND IN SOME HEMATOLOGICAL DISEASES. (PRELIMINARY COMMUNICATION)].
    SZMIGIELSKI S; LITWIN J
    Pol Arch Med Wewn; 1964; 34():319-21. PubMed ID: 14159671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.